Nephrotoxicity of cisplatin, carboplatin and transplatin
- 1 July 1990
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 64 (5) , 393-400
- https://doi.org/10.1007/bf01973462
Abstract
The present study was designed to compare the nephrotoxicity induced by the three platinum compounds cisplatin (CDDP), carboplatin (CBDCA) and transplatin (TDDP) in vitro and to obtain information to elucidate the mechanism of platinum compound-induced nephrotoxicity. Rat or rabbit renal cortical slices were incubated for different periods of time in platinum compound-containing media (0.42 or 1.67 mM) and thereafter monitored for platinum content, tetraethylammonium(TEA) and paraaminohippurate(PAH) accumulation and gluconeogenesis. Malondialdehyde(MDA) content of slices was determined as a parameter of lipid peroxidation. Activity of glucose-6-phosphatase of rat renal microsomes was investigated after platinum-compound exposure. In all series of experiments the effect of the antioxidant N,N′diphenyl-p-phenylenediamine (DPPD) was tested. CBDCA showed no effects on all parameters of renal cell function at all concentrations and all time points investigated, except for the activity of glucose-6-phosphatase, which was slightly affected by CBDCA. CBDCA-induced MDA production was lower, compared to CDDP, which showed marked toxic effects on TEA and PAH accumulation, gluconeogenesis and glucose-6-phosphatase activity. The onset of CDDP-induced alterations was dependent on drug concentration. MDA production was reduced by DPPD. Protection against the platinum compound-induced decrease in TEA and PAH accumulation was observed after the use of DPPD. DPPD had no protective effect on CDDP-induced inhibition of gluconeogenesis and glucose-6-phosphatase, which might indicate an effect on gluconeogenesis by direct inhibition of glucose-6-phosphatase. DPPD did not alter uptake of platinum compounds in rat renal cortical slices. TDDP showed different in vitro properties compared to in vivo conditions. In conclusion, association of CDDP-induced nephrotoxicity with lipid peroxidation was shown. CBDCA induced less generation of lipid peroxidation products and only very small nephrotoxic effects. Antioxidants may restrict CDDP-induced alterations in renal cell function.Keywords
This publication has 36 references indexed in Scilit:
- Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activityBiochemical and Biophysical Research Communications, 1989
- Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- The use of renal cortical slices from the Fischer 344 rat as an in vitro model to evaluate nephrotoxicity*1Fundamental and Applied Toxicology, 1988
- Effect of the Antioxidant N,N1=Diphenyl=p phenylenediamine (DPPD) on Bromobenzene Metabolism and Toxicity in Isolated HepatocytesBasic & Clinical Pharmacology & Toxicology, 1988
- Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat*1Fundamental and Applied Toxicology, 1988
- Effect of N-N'-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats.The Japanese Journal of Pharmacology, 1988
- Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicityBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Uptake and metabolism of cisplatin by rat kidneyKidney International, 1984
- Control of renal cortex ammoniagenesis and its relationship to renal cortex gluconeogenesisBiochimica et Biophysica Acta (BBA) - General Subjects, 1974
- Metabolism of phospholipids IX. Phosphatidate phosphohydrolase in rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1965